Currency In USD
| Previous Close | 10.2 |
| Open | 10.24 |
| Day High | 10.25 |
| Day Low | 10.22 |
| 52-Week High | 10.8 |
| 52-Week Low | 9.94 |
| Volume | 2,107 |
| Average Volume | 277 |
| Market Cap | 712.82M |
| PE | 0 |
| EPS | 0 |
| Moving Average 50 Days | 10.18 |
| Moving Average 200 Days | 10.1 |
| Change | 0.05 |
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
GlobeNewswire Inc.
Dec 03, 2025 11:34 AM GMT
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted company, today announced that commencing December 3, 2025,
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
GlobeNewswire Inc.
Sep 26, 2025 8:05 PM GMT
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross proceed
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
GlobeNewswire Inc.
Sep 25, 2025 10:43 AM GMT
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announced today the pricing yesterday of its initial public offering of 50,000,000 units at $10.00 per unit. The uni